ID
36075
Description
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02492711
Lien
https://clinicaltrials.gov/show/NCT02492711
Mots-clés
Versions (1)
- 14/04/2019 14/04/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
14 avril 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility HER-2 Positive Breast Cancer NCT02492711
Eligibility HER-2 Positive Breast Cancer NCT02492711
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Metastatic malignant neoplasm to brain Untreated
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0220650
- UMLS CUI [1,2]
- C0332155
Description
Seizures Uncontrolled
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0036572
- UMLS CUI [1,2]
- C0205318
Description
Allogeneic bone marrow transplantation | Allogeneic Stem Cell Transplantation | Solid organ transplant Allogeneic
Type de données
boolean
Alias
- UMLS CUI [1]
- C0149615
- UMLS CUI [2]
- C2242529
- UMLS CUI [3,1]
- C0730400
- UMLS CUI [3,2]
- C1515895
Description
Cardiovascular Disease
Type de données
boolean
Alias
- UMLS CUI [1]
- C0007222
Description
Pulmonary function impairment | Requirement Supplemental oxygen
Type de données
boolean
Alias
- UMLS CUI [1]
- C0858943
- UMLS CUI [2,1]
- C1514873
- UMLS CUI [2,2]
- C4534306
Description
Medical contraindication Trastuzumab | Condition Preventing Chemotherapy
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0728747
- UMLS CUI [2,1]
- C0348080
- UMLS CUI [2,2]
- C1292733
- UMLS CUI [2,3]
- C0392920
Similar models
Eligibility HER-2 Positive Breast Cancer NCT02492711
- StudyEvent: Eligibility
C2348909 (UMLS CUI [1,2])
C0346993 (UMLS CUI [2,1])
C2348909 (UMLS CUI [2,2])
C0205269 (UMLS CUI [2,3])
C3495949 (UMLS CUI [3,1])
C2348909 (UMLS CUI [3,2])
C0205336 (UMLS CUI [3,3])
C3495949 (UMLS CUI [4,1])
C2348909 (UMLS CUI [4,2])
C0205269 (UMLS CUI [4,3])
C1562312 (UMLS CUI [5])
C1562928 (UMLS CUI [6])
C2584629 (UMLS CUI [7])
C2584628 (UMLS CUI [8])
C0728747 (UMLS CUI [2])
C2935436 (UMLS CUI [3])
C4086621 (UMLS CUI [4])
C4084850 (UMLS CUI [5])
C4085632 (UMLS CUI [6])
C0279134 (UMLS CUI [7])
C1514460 (UMLS CUI [8])
C1265611 (UMLS CUI [1,2])
C4085632 (UMLS CUI [1,3])
C0242656 (UMLS CUI [2])
C0678226 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1302210 (UMLS CUI [2])
C1514893 (UMLS CUI [3,1])
C1516728 (UMLS CUI [3,2])
C1879533 (UMLS CUI [1,2])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332155 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
C2242529 (UMLS CUI [2])
C0730400 (UMLS CUI [3,1])
C1515895 (UMLS CUI [3,2])
C1514873 (UMLS CUI [2,1])
C4534306 (UMLS CUI [2,2])
C0728747 (UMLS CUI [1,2])
C0348080 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])